Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Bloqueio do nervo do plexo braquial versus tratamento padrão para redução fechada da fratura do rádio distal em adultos - o ensaio BLOCK. um ensaio nacional multicêntrico randomizado controlado

16 de setembro de 2026 atualizado por: Nordsjaellands Hospital

The aim of the project is to evaluate the beneficial and harmful effects of an ultrasound-guided brachial plexus nerve block for patients with a distal radius (wrist) fracture in the need of realignment of fractured bone endings without cutting the skin (closed reduction), in comparison to a haematoma block, which is standard care in Denmark.

Every participant will receive one of the following types of anaesthesia for the realignment of the wrist fracture:

  1. A nerve block of the arm (plexus brachialis block)
  2. A haematoma block, which is the current standard anaesthesia in the emergency departments.

Visão geral do estudo

Tipo de estudo

Intervencional

Inscrição (Estimado)

1716

Estágio

  • Fase 4

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Locais de estudo

    • Capital Region
      • Hillerød, Capital Region, Dinamarca, 3400
        • Copenhagen University Hospital - North Zealand Hillerød

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

18 anos e mais velhos (Adulto, Adulto mais velho)

Aceita Voluntários Saudáveis

Não

Gêneros Elegíveis para o Estudo

Tudo

Descrição

Inclusion Criteria:

  • Adults (age ≥ 18 years) with a distal radius fracture in need of closed reduction

Exclusion Criteria:

  • Patients who would never qualify for surgery according to local guidelines
  • Lack of informed consent
  • No Danish Central Person Register (CPR) number
  • Allergies to the trial medication
  • Distal radius fracture initially deemed to require surgery regardless of the outcome of the closed reduction
  • Open fractures (fracture-related wound requiring sutures)
  • Other fractures on the same extremity ((NOT including distal ulna fracture(s))
  • Bilateral distal radius fractures both requiring closed reduction
  • Concomitant medical or surgical condition taking priority over the closed reduction of the distal radius fracture.

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Tratamento
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Dobro

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: Intervention group

Ultrasound-guided brachial plexus nerve block. A total of 30 ml of lidocaine (10 mg/ml) with adrenaline (5 ug/ml) will be administered in multiple injections.

The block will be performed as either a lateral infraclavicular brachial plexus block or an axillary brachial plexus block

Comparador Ativo: Control group

Haematoma block with local anaesthetics i.e. lidocaine with adrenaline

Participants will receive no peripheral nerve block and receive a haematoma block, with or without supplemental sedation and/or systemic analgesia for the closed reduction according to local guidelines and clinical practices

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Prazo
Proporção cumulativa de pacientes com cirurgia de fratura distal do rádio
Prazo: 90 dias após redução fechada
90 dias após redução fechada

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Composite outcome of treatment related complications
Prazo: 90 days after closed reduction

loco-regional neurological complications from affected arm, local anaesthetic systemic toxicity, soft tissue injuries (including skin injuries) related to the closed reduction procedure, infection at the site of needle puncture, vessel puncture requiring subsequent treatment (including compression), pneumothorax, allergic reaction, new bone or joint injury (e.g. dislocation or fracture) after the closed reduction and/or pulmonary embolism

90 days after closed reduction
Patient Rated Wrist Evaluation (PRWE)
Prazo: 90 days after closed reduction

The PRWE is a patient-reported outcome and the PRWE-score is calculated from the Danish-validated translation of the PRWE questionnaire

90 days after closed reduction
Maximum pain score in the affected wrist during closed reduction(s)
Prazo: 0-12 hours after the closed reduction

The pain outcomes are patient-reported as a Numerical Rating Scale (NRS) score on a scale from 0=no pain to 10=worst pain imaginable. If the patient has the closed reduction performed more than one time, the patient will be asked to report the worst pain experienced during all the attempts of a closed reduction.

0-12 hours after the closed reduction
Proportion of patients with unacceptable radiographic fracture position immediately after closed reduction
Prazo: 0 -24 hours after closed reduction

The radiographic fracture position is evaluated according to the American Academy of Orthopaedic Surgerons (AAOS) guidelines. The fracture position is unacceptable if the fracture has a radial shortening > 3 mm, > 10 degrees dorsal tilt of the articular surface of radius from a perpendicular line on the longitudianal axis of radius or intra-articular displacement or step-off > 2 mm.

0 -24 hours after closed reduction

Outras medidas de resultado

Medida de resultado
Descrição da medida
Prazo
Número de tentativas usadas para redução fechada
Prazo: Imediatamente após a redução fechada
Imediatamente após a redução fechada
Proporção de complicações individuais no desfecho secundário composto
Prazo: 90 dias após redução fechada
90 dias após redução fechada
Pain at rest in the affected wrist immediately, 90 days, and 12 months after closed reduction
Prazo: 0-12 hours, 90 days and 12 months after closed reduction

The pain outcomes are patient-reported as a Numerical Rating Scale (NRS) score on a scale from 0=no pain to 10=worst pain imaginable.

0-12 hours, 90 days and 12 months after closed reduction
Maximum pain in the affected wrist within the first 24 hours after closed reduction
Prazo: 24-36 hours after the closed reduction.

The pain outcomes are patient-reported as an NRS score on a scale from 0=no pain to 10=worst pain imaginable.

24-36 hours after the closed reduction.
Proportion of patients with complex regional pain syndrome (CRPS)
Prazo: 90 days and 12 months after closed reduction

CRPS is defined according to the Budapest Criteria

90 days and 12 months after closed reduction
Disabilities of the Arm, Shoulder, and Hand (DASH) score
Prazo: 90 days and 12 months after closed reduction

DASH-score is calculated from the Danish-validated translation of the DASH questionnaire

90 days and 12 months after closed reduction
Patient Rated Wrist Evaluation (PRWE)
Prazo: 12 months after closed reduction

PRWE-score is calculated from the Danish-validated translation of the PRWE questionnaire

12 months after closed reduction
Quality of life (EQ-5D-5L) score
Prazo: 90 days and 12 months after closed reduction

The Danish translation of the EQ-5D-5L questionnaire is used and the EQ-5D-5L-score is calculated based on the Danish EQ-5D-5L value set

90 days and 12 months after closed reduction
Difficulty of closed reduction of the fracture
Prazo: Immediately after closed reduction

The doctor reported ease on a numeric rating scale from 0-10; 0=very easy, 10=very difficult)

Immediately after closed reduction
Discomfort related to the anaesthetic procedure
Prazo: 0-12 hours after closed reduction

The discomfort is a patient-reported outcome on a numeric rating scale from 0-10; 0=no discomfort, 10=very uncomfortable

0-12 hours after closed reduction
Overall satisfaction with the treatment 0 to 24 hours after initiation of the anaesthesia
Prazo: 24 hours after closed reduction

The overall satisfaction is a patient-reported outcome on a numeric rating scale from 0-10; 0=very unsatisfied, 10=very satisfied. When evaluating the treatment, the patient is specifically asked to include all elements of the treatment including: the anaesthetic (procedure and following effects), the experience during the closed reduction and the pain and general sensation in the arm/wrist in the first 24 hours after the treatment commencement.

24 hours after closed reduction
Proportion of patients with unacceptable radiographic position at first follow-up in the orthopaedic out-patient clinic (typically 10-14 days post-reduction)
Prazo: 10-14 days after closed reduction

The radiographic fracture position is evaluated according to the American Academy of Orthopaedic Surgerons (AAOS) guidelines. The fracture position is unacceptable if the fracture has a radial shortening > 3 mm, > 10 degrees dorsal tilt of the articular surface of radius from a perpendicular line on the longitudianal axis of radius or intra-articular displacement or step-off > 2 mm.

10-14 days after closed reduction
Proportion of patients having one or more serious adverse events (SAEs), including events related to loss of hand function
Prazo: Within 90 days after closed reduction

A SAE is defined as an adverse event that leads to the following incidents:

  • Death
  • Life threatening injury or disease
  • Severe or permanent disability
  • Admission to the hospital or prolongation of hospitalisation

Surgical reduction of the distal radius fracture, including relevant admission to hospital, will not be catagorised as a SAE.

Within 90 days after closed reduction
Proportion of patients having one or more adverse events (AEs)
Prazo: Within 24 hours after closed reduction

An AE is defined as any harmful and unintended event, sign, or symptom, that appear during the trial period, regardless of whether this AE is considered related to the treatment or not.

Within 24 hours after closed reduction

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Investigadores

  • Investigador principal: Cecilie D Harwood, MD, PhD-fellow, Copenhagen University Hospital - North Zealand
  • Investigador principal: Anne-Sofie Jellestad, MD, PhD-fellow, Copenhagen University Hospital - North Zealand

Publicações e links úteis

A pessoa responsável por inserir informações sobre o estudo fornece voluntariamente essas publicações. Estes podem ser sobre qualquer coisa relacionada ao estudo.

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Real)

10 de dezembro de 2024

Conclusão Primária (Estimado)

24 de novembro de 2026

Conclusão do estudo (Estimado)

24 de agosto de 2027

Datas de inscrição no estudo

Enviado pela primeira vez

6 de novembro de 2024

Enviado pela primeira vez que atendeu aos critérios de CQ

6 de novembro de 2024

Primeira postagem (Real)

7 de novembro de 2024

Atualizações de registro de estudo

Última Atualização Postada (Real)

21 de setembro de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

16 de setembro de 2026

Última verificação

1 de setembro de 2026

Mais Informações

Termos relacionados a este estudo

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

NÃO

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever